Case Report
A Case of Nonfunctioning Pituitary Carcinoma That Responded to Temozolomide Treatment
Table 1
The patient’s pituitary hormones at admission.
| Pituitary hormone | Result | Reference range |
| LH | 0.10 mIU/mL | 0.79–5.72 | FSH | 0.67 mIU/mL | 2.00–8.30 | Testosterone | 0.05 ng/mL | 2.01–7.50 | GH | 0.340 ng/mL | 0.003–0.971 | IGF-1 | 170 ng/mL | 81–235 | PRL | 10.5 ng/mL | 3.7–16.3 | ACTH | 33.6 pg/mL | 7.0–56.0 | Cortisol | 4.1 g/dL | 4.5–21.1 | Free T3 | 2.36 pg/mL | 2.1–4.1 | Free T4 | 0.92 ng/dL | 0.95–1.74 | TSH | 3.470 IU/mL | 0.38–3.64 |
|
|